Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products – Stockhouse

Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products Stockhouse Merz Aesthetics offers a tailored and harmonized portfolio of products for minimally invasive treatments and Merz is an important player in the US aesthetics market with products Radiesse , the neurotoxin Xeomin and the filler Belotero. In the Consumer … and more